Gohealth Inc has
performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e. Beta) of -0.029, which attests to not very significant fluctuations relative to the market. Let's try to break down what Gohealth's beta means in this case. As returns on the market increase, returns on owning Gohealth Inc are expected to decrease at a much lower rate. During the bear market, Gohealth Inc is likely to outperform the market. Although it is extremely important to respect
Gohealth Inc Cl current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By evaluating
Gohealth Inc Cl technical indicators, you can presently evaluate if the expected return of 0.0773% will be sustainable into the future.
Gohealth Inc Cl right now retains a risk of 5.29%. Please check out Gohealth Inc
potential upside, and the
relationship between the
total risk alpha and
kurtosis to decide if Gohealth Inc will be following its current trending patterns.
What is the right price you would pay to acquire a share of GoHealth? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the
future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our
stock advisor page.
What is happening with GoHealth this year
Annual and quarterly reports issued by GoHealth are formal
financial statements that are published yearly and quarterly and sent to GoHealth stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the
Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as GoHealth often view their annual report as an effective marketing tool to disseminate their perspective on company
future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.
GoHealth Gross Profit
GoHealth Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing GoHealth previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show GoHealth Gross Profit growth over the last 10 years. Please check GoHealth's
gross profit and other
fundamental indicators for more details.
Is GoHealth valued appropriately by the market?
Average experts consensus on the firm has changed. Currently, most analysts have less confidence in Gohealth Inc Cl as compared to a month ago. The current buy or sell recommendation of 8 analysts is Buy.
Is Gohealth a risky opportunity?
Let's check the volatility. Gohealth is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Gohealth (NASDAQ:GOCO) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. picking up a share of a Gohealth Inc stock makes you a part-owner of that company.
Gohealth Inc Cl Current Consensus
Here is the latest trade recommendation based on an ongoing consensus estimate among financial analysis covering Gohealth Inc Cl. The Gohealth consensus assessment is calculated by taking the average estimates from all of the analysts covering Gohealth Inc
| Strong Buy | 6 | 75.0 |
| Buy | 1 | 12.5 |
| Hold | 1 | 12.5 |
| Sell | 0 | 0.0 |
| Strong Sell | 0 | 0.0 |
Gohealth Inc is projected to stay under $19.41 in September
Downside variance is down to 27.47. It may entail a possible volatility slide. Gohealth Inc Cl exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Gohealth Inc Cl individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Gohealth Inc future systematic risk.
Our Conclusion on Gohealth Inc
Whereas some other companies in the insurance brokers industry are either recovering or due for a correction, Gohealth may not be as strong as the others in terms of longer-term growth potentials. The inconsistency in the assessment between current Gohealth valuation and our trade advice on Gohealth Inc is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Gohealth Inc.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of GoHealth. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
